More than two million people in the United States have a diagnosis of schizophrenia. For the last half century, the treatment for most has consisted mainly of antipsychotic medications that blunt hallucinations and delusions but which may also come with significant and unpleasant side effects. Recently, there has been remarkable new research in understanding and treating this debilitating mental illness.
In this program a neuropsychologist reports on new neurodevelopmental models of etiology and the many risk factors that can give rise to schizophrenia and to the psychosis-spectrum disorders. Next, the program director of one of the clinical sites used to study psychosis discusses how schizophrenia can be treated in its early stage. Following that, a psychiatrist explains how he applies self-psychology in his very close and connected treatment of early episode patients. Finally, the mother of a schizophrenic child discusses what the families of these patients need -- and don't receive.
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses, case workers.
This CE course is designated as intermediate.
There is no known conflict of interest or commercial support.
Format: Asynchronous, distance learning. Non-interactive. Recorded audio with transcript.
Content Category: Clinical
You can access the audio to these interviews via your computer's MP3 player and/or read the text of the interviews.